Literature DB >> 5360525

Immunological and other biological characteristics of pentons of human adenoviruses.

G Wadell, E Norrby.   

Abstract

Comparative hemagglutination-enhancement (HE) tests demonstrated diversified patterns of antigenic specificities both in the fiber and vertex capsomer part of pentons of human adenovirus types 3, 11 (subgroup I), 9, 15 (II), 1, 2, 4, 5, 6 (III), and 12. All fibers contained a type-specific antigen. Subgroup II and III fibers, in addition, contained specificities both unique for each subgroup and also common to the two subgroups. Fibers of serotypes 4 and 12 displayed a somewhat deviating behavior. All vertex capsomers tested shared a group-specific part. This was the only antigenic specificity demonstrable for serotype 12. Maximal penton HE titers of all sera were reached in tests with incomplete hemagglutinin of type 11. In addition, maximal HE activity of sera against individual serotypes also was recorded against pentons of other members of the same subgroup. Antigen characteristics of vertex capsomers of type 4 indicated a closer relationship to subgroup I than to subgroup III. The toxin activity of pentons was more sensitive to trypsin treatment than their capacity to function as incomplete hemagglutinin. Homotypic antipenton sera, unabsorbed or absorbed with homotypic fibers to remove antibodies against this component, and, to a varying extent, also heterotypic antipenton sera could neutralize toxin activity. Antifiber sera could neutralize toxin activity of pentons carrying short fibers (10 nm, type 3) but not of those carrying long fibers (28 to 31 nm, type 2). It is concluded that toxin activity is carried by a specific part of vertex capsomers and that cell detachment can be brought about via a direct contact between this component and cell membranes. Fiber-mediated attachment does not seem to be necessary for this biological activity to become expressed.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5360525      PMCID: PMC375924     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  The relationship between soluble antigens and the virion of adenovirus type 3. 3. Immunological identification of fiber antigen and isolated vertex capsomer antigen.

Authors:  E Norrby; P Skaaret
Journal:  Virology       Date:  1967-07       Impact factor: 3.616

2.  Structural proteins of adenoviruses. I. Purification and characterization of the adenovirus type 2 hexon antigen.

Authors:  U Pettersson; L Philipson; S Höglund
Journal:  Virology       Date:  1967-12       Impact factor: 3.616

3.  Role of adenovirus antigens in the induction of virus neutralizing antibody.

Authors:  L Kjellén; H G Pereira
Journal:  J Gen Virol       Date:  1968-01       Impact factor: 3.891

4.  Antigens and structure of the adenovirus.

Authors:  R C Valentine; H G Pereira
Journal:  J Mol Biol       Date:  1965-08       Impact factor: 5.469

5.  Identification of soluble components of adenovirus type 11.

Authors:  E Norrby
Journal:  J Gen Virol       Date:  1968-01       Impact factor: 3.891

6.  Adenovirus antigens--a study of their properties and sequential development in infection.

Authors:  W C Russell; K Hayashi; P J Sanderson; H G Pereira
Journal:  J Gen Virol       Date:  1967-10       Impact factor: 3.891

7.  Ultrastructure of soluble antigens and the virion of adenovirus type 4.

Authors:  G Wadell; E Norrby; U Schönning
Journal:  Arch Gesamte Virusforsch       Date:  1967

8.  Soluble components of adenovirus type 4.

Authors:  E Norrby; G Wadell
Journal:  Virology       Date:  1967-04       Impact factor: 3.616

9.  The relationship between the soluble antigens and the virion of adenovirus type 3. I. Morphological characteristics.

Authors:  E Norrby
Journal:  Virology       Date:  1966-02       Impact factor: 3.616

10.  The relationship between the soluble antigens and the virion of adenovirus type 3. II. Identification and characterization of an incomplete hemagglutinin.

Authors:  E Norrby
Journal:  Virology       Date:  1966-12       Impact factor: 3.616

View more
  15 in total

1.  Sequence analysis of porcine adenovirus serotype 5 fibre gene: evidence for recombination.

Authors:  Miklós Nagy; Eva Nagy; Tamás Tuboly
Journal:  Virus Genes       Date:  2002-03       Impact factor: 2.332

2.  Association of endonuclease activity with serotypes belonging to the three subgroups of human adenoviruses.

Authors:  R G Marusyk; A R Morgan; G Wadell
Journal:  J Virol       Date:  1975-08       Impact factor: 5.103

3.  A human cell line selected for resistance to adenovirus infection has reduced levels of the virus receptor.

Authors:  P Freimuth
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

4.  A protein factor of adenovirus type 9--15 virion inducing late cytotoxicity.

Authors:  H L Shu; P Chu; J Djimjadi; E K Yap
Journal:  Arch Gesamte Virusforsch       Date:  1974

5.  Neutralization of adenovirus toxins: specificity and antigenic relationships.

Authors:  N Döring; C X Nguyen; R Wigand
Journal:  Med Microbiol Immunol       Date:  1972       Impact factor: 3.402

6.  Immunological relationships between hexons of certain human adenoviruses.

Authors:  E Norrby; G Wadell
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

7.  Capsid mosaics of intermediate strains of human adenoviruses.

Authors:  E Norrby
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

8.  Multiple adenovirus serotypes use alpha v integrins for infection.

Authors:  P Mathias; T Wickham; M Moore; G Nemerow
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

9.  Evidence that the penton base of adenovirus is involved in potentiation of toxicity of Pseudomonas exotoxin conjugated to epidermal growth factor.

Authors:  P Seth; D Fitzgerald; H Ginsberg; M Willingham; I Pastan
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

10.  Vero microcultures for adenovirus neutralization tests.

Authors:  J C Hierholzer; P G Bingham
Journal:  J Clin Microbiol       Date:  1978-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.